Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2025-12-29 @ 3:07 AM
Study NCT ID:
NCT05429294
Status:
UNKNOWN
Last Update Posted:
2022-06-23
First Post:
2022-06-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Novel Double Target Therapy Combined With Chemotherapy in First-line Treatment of HER2+ Breast Cancer, MA-BC-II-038
Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-18
First Submit QC Date:
None
Study First Post Date:
2022-06-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-18
Last Update Post Date:
2022-06-23
Last Update Post Date Type:
ACTUAL